Boston Scientific Halts Imager II Catheter Sales After Two Serious Injuries, Adding To A Difficult Year
Daniel Cho
Coverage
Medical Technology
Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
Latest
Implantica Wins FDA Approval For RefluxStop, Eight Years After European Launch
Michael Torres
Roche And Eli Lilly Win FDA Clearance For Elecsys pTau217, Opening A New Alzheimer’s Blood-Test Step
Jonathan Blake
STAT Details Focal Therapy’s Rise In Prostate Cancer As Guidelines Still Limit Use
Emily Carter
Most read
Brain-Computer Interface Breakthrough Empowers People with Paralysis to Type Using Their Minds
Jonathan Blake
Abridge’s Strategic Evolution: Clinical AI Platform Expansion, New Pharma Alliances, and Fundraising Milestones
Jonathan Blake
AI Won’t Fix Physician Burnout — Giving Them More Autonomy Will
Michael Torres
Apella Raises $80M Series B to Optimize Hospital Operating Rooms with AI
TCB Team
More in this beat
Aug 21, 2026Focal Therapy Posts 0.1% Prostate Cancer Mortality At 10 Years, While U.S. Guidelines Still Call It Experimental
Focal therapy aims to destroy MRI-visible prostate lesions without removing or irradiating the whole gland, offering a less aggressive option than surgery or radiation for some patients with localized disease. A recent 10-year U.K. study reported 0.1% prostate cancer mortality, but the American Urological Association still says the approach should be limited to studies and prospective registries.
Emily Carter
Aug 12, 2026STAT Investigation Examines Commure’s Referral Payments And Customer Losses, As AI Health-Care Sales Scale
Commure, a Mountain View technology company valued at $7 billion, is pitching AI tools meant to automate billing, scheduling, and clinical documentation across health care. The STAT report puts the focus less on product ambition than on the commercial methods and customer outcomes shaping adoption as AI moves deeper into provider operations.
Sophia Reynolds
Aug 8, 2026Healthcare Workplace Violence Prevention: Why Risk Visibility Must Improve
Although healthcare organizations routinely collect data on potential risk indicators, the inability to connect disparate pieces of information often leads to missed warning signs and reactive, rather than proactive, prevention efforts. This extended analysis explores the systemic barriers and examines pathways toward more effective workplace violence prevention in healthcare—including the critical role of emerging data technologies.
Dr. Alex Morgan
Aug 7, 2026Rethinking Preventive Dental Care: Why the Bite Is the Missing Piece
While dentistry’s preventive paradigm has long targeted cavities and periodontal disease, new thought leadership emphasizes that how teeth, muscles, and the jaw interact over a lifetime plays a foundational role in holistic oral health. As emerging science connects bite function to chronic dental problems, the industry is re-examining what truly constitutes prevention.
Dr. Priya Nandakumar
Aug 6, 2026UnityPoint Health’s AI-Driven Approach Targets Clinician Burnout
UnityPoint Health is implementing a suite of artificial intelligence (AI) solutions across its health system to streamline administrative tasks and help clinicians refocus on patient care. These measures range from real-time capacity tracking and ambient documentation to advanced AI-powered medical record review, reflecting a technology-first approach to combatting widespread burnout in healthcare.
Dr. Alex Morgan
Aug 4, 2026Report: Telehealth Uptake Is Lagging in Rural Areas
A persistent gap in telehealth adoption between rural and non-rural populations raises fresh questions about equitable digital health access. This new report illuminates the scale of the problem—and spotlights the challenges ahead for policymakers, providers, and technology innovators.
Michael Torres
Jul 23, 2026Assured Health Secures $19M for AI-Driven Healthcare Credentialing: Can Agentic Automation Redefine Provider Onboarding?
Assured Health has raised $19 million for its AI agent platform, which promises to streamline and automate the provider credentialing and insurance onboarding process for health systems. The startup claims its technology can reduce timelines from months to days, potentially reshaping a major industry pain point.
Jonathan Blake
Jul 21, 2026Nabla Appoints New CEO as It Seeks Market Share in Crowded AI Scribe Landscape
Nabla, a Paris-based AI-driven medical scribe company, has announced Brian Manning as its new CEO. The leadership change comes at a strategic moment as digital scribe vendors face mounting pressure to differentiate their technology and expand reach in the crowded clinical documentation market.
Emily Carter
Jul 20, 2026Are We Entering an Interoperability Trust Recession? Examining the Next Stage of Healthcare Data Evolution
A growing number of healthcare entities have raised concerns over a perceived decline in trust surrounding interoperability, the seamless exchange and use of health data across multiple systems and organizations. This in-depth analysis explores what a so-called 'trust recession' could mean for the industry's digital maturity, and outlines what entities should be watching for as the next chapter in healthcare data unfolds.
Dr. Priya Nandakumar
Jul 19, 2026MDCalc Launches Quality Ratings to Assess Over 800 Clinical Calculators for Bias and Validity
As clinical algorithms proliferate in modern healthcare, concerns about validity and bias have also increased. MDCalc’s new system sets out to bring more transparency and rigor to the digital tools underpinning millions of daily medical decisions.
Daniel Cho
Jul 18, 2026‘Bot vs. Bot’: How Automated Authorizations Are Fueling Healthcare Costs
The escalation of artificial intelligence and automated software in healthcare’s prior authorization and reimbursement processes is creating a heavily automated ‘arms race’ between payers and providers. Industry insiders now warn that this competitive automation increases administrative costs and may ultimately complicate patient care—unless genuine data interoperability and collaboration occur.
Dr. Alex Morgan
Jul 15, 2026Advancements in Alzheimer’s Diagnostics Could Revolutionize Accessibility and Clinical Insights
Alzheimer’s diagnostics is on the cusp of transformation with innovative techniques providing broader access and richer clinical data. Improvements in testing methods may offer earlier detection and foster more informed treatment strategies as researchers chart new territory in dementia diagnostics.
Sophia ReynoldsOther beats
AI in Drug Discovery
Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Biopharmaceutical Industry
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Biotech Innovation
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Healthcare Investment
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
Regulatory & Policy
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.